Continuation of Research and Development Activities
First written in FY2017-Q1. 21 of 28 entries say "Restated". Latest entry: FY2026.
45 other companies' latest entry also says "Other".
- FY2026Progress toward global standards compliance and PA improvementsAnnual report
「As a result, during the fiscal year, the Company proceeded with development to make its take-out robots compatible with global standards for customers worldwide, as well as improved designs for the PA series of palletizing robots to strengthen product capabilities. The Company also made design changes to existing products as needed to ensure a stable supply of products and after-sales services.」
In addition to continuing its research and development policy, the Company specified global standards compliance, improved designs for the PA series and design changes to existing products as areas of focus. Research and development expenses were ¥901.304 million. - FY2026-H1RestatedAnnual report
「The Group's total research and development expenses for the six-month interim consolidated period were ¥420.255 million. There were no material changes in the status of the Group's research and development activities during the six-month interim consolidated period.」
The disclosure states that there were no material changes in research and development activities while reporting total research and development expenses of ¥420.255 million. - FY2024AdvancedAnnual report
「As a result, during the fiscal year, the Company released the PA-50LC from the PA series of palletizing robots. Compared with the previous model, it has a lower overall height and greater conveying capacity.」
The PA-50LC was released during the full fiscal year as a result of research and development, and research and development expenses were ¥492.287 million. - FY2024-Q2AdvancedAnnual report
「The Group's total research and development expenses for the six months ended the second quarter were ¥236.538 million. The changes by segment in the status of research and development activities during the six months ended the second quarter were as follows. (Europe) All research and development expenses had previously been incurred in Japan. However, because the Company acquired all shares of WEMO Automation AB, which conducts research and development activities, and included it in the scope of consolidation, Europe has also been included from the six months ended the second quarter.」
Following the consolidation of WEMO Automation AB, Europe was added as a segment in which research and development activities are conducted. Total research and development expenses were ¥236.538 million. - FY2023AdvancedAnnual report
「As a result, during the fiscal year, the Company released the CTM-V series of rotary take-out robots, which achieve ultra-high-speed take-out with a compact body. In addition, the Company proceeded with product development tailored to specific regions and customer industries. Amid continuing global difficulties in procuring components, the Company also made design changes to existing products as needed to ensure a stable supply of products and after-sales services. All ¥399.593 million of research and development expenses for the fiscal year were incurred in Japan.」
The CTM-V series was released, while product development by region and industry and design changes to existing products were also pursued in response to difficulties in procuring components. Research and development expenses were ¥399.593 million. - FY2023-Q3RestatedAnnual report
「The Group's total research and development expenses for the nine months ended the third quarter were ¥295.883 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」
The disclosure continues the policy of stating that there have been no material changes in research and development activities and reports total research and development expenses of ¥295.883 million. - FY2023-Q2RestatedAnnual report
「The Group's total research and development expenses for the six months ended the second quarter were ¥193.852 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」
The disclosure continues to state that there have been no material changes in research and development activities and reports total research and development expenses of ¥193.852 million. - FY2023-Q1RestatedAnnual report
「The Group's total research and development expenses for the three months ended the first quarter were ¥96.782 million. There were no material changes in the status of the Group's research and development activities during the three months ended the first quarter.」
The disclosure continues the policy of stating that there have been no material changes in research and development activities, and reports total research and development expenses of ¥96.782 million. - FY2022RestatedAnnual report
「To develop products that meet the needs of a wide range of industries worldwide, the Group is pursuing multiple research and development projects in parallel at each of the basic research, component development and applied development stages.」
The policy of pursuing research and development projects in parallel across multiple stages has been reaffirmed. - FY2022-Q3RestatedAnnual report
「The Group's total research and development expenses for the nine months ended the third quarter were ¥267.130 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」
The disclosure continues to state that there have been no material changes in research and development activities and reports total research and development expenses of ¥267.130 million. - FY2022-Q2RestatedAnnual report
「The Group's total research and development expenses for the six months ended the second quarter were ¥177.717 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」
The disclosure continues the policy of stating that there have been no material changes in research and development activities, and reports total research and development expenses of ¥177.717 million. - FY2022-Q1RestatedAnnual report
「The Group's total research and development expenses for the three months ended the first quarter were ¥92.728 million. There were no material changes in the status of the Group's research and development activities during the three months ended the first quarter.」
The disclosure continues the policy of stating that there have been no material changes in research and development activities, and reports total research and development expenses of ¥92.728 million. - FY2021AdvancedAnnual report
「As a result, during the fiscal year, the Company released the LA series of take-out robots for large molding machines, the SD series of take-out robots for the Asian market, and the PA series of palletizing robots. All ¥347.588 million of research and development expenses for the fiscal year were incurred in Japan.」
Multiple research and development projects were pursued in parallel, and 3 series were launched. Research and development expenses were ¥347.588 million. - FY2021-Q3RestatedAnnual report
「The Group's total research and development expenses for the nine months ended the third quarter were ¥251.145 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」
The disclosure states that research and development expenses were ¥251.145 million and that there were no material changes in research and development activities. - FY2021-Q2RestatedAnnual report
「The Group's total research and development expenses for the six months ended the second quarter were ¥162.922 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」
The disclosure states that research and development expenses were ¥162.922 million and that there were no material changes in research and development activities. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the Group during the cumulative third quarter of the current fiscal year were ¥73.071 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current fiscal year.」
The disclosure continues to state that there have been no material changes in research and development activities. Total research and development expenses were ¥73.071 million. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the Group during the cumulative second quarter of the current fiscal year were ¥196.580 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current fiscal year.」
The disclosure that there have been no material changes in research and development activities continues. Total R&D expenses were ¥196.580 million. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the Group during the cumulative first quarter of the current fiscal year were ¥105.555 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current fiscal year.」
The disclosure that there have been no material changes in research and development activities continues. R&D expenses were ¥105.555 million. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the Group during the cumulative third quarter of the current fiscal year were ¥308.039 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current fiscal year.」
The disclosure states that R&D expenses were ¥308.039 million and that there were no material changes in research and development activities. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the Group during the cumulative second quarter of the current fiscal year were ¥194.227 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current fiscal year.」
The disclosure that there have been no material changes in research and development activities continues. Total R&D expenses were ¥194.227 million. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the Group during the cumulative first quarter of the current fiscal year were ¥93.934 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current fiscal year.」
The disclosure that there have been no material changes in research and development activities continues. Total R&D expenses were ¥93.934 million. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the Group during the cumulative third quarter of the current fiscal year were ¥539.779 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current fiscal year.」
The disclosure that there have been no material changes in research and development activities continues. Total R&D expenses were ¥539.779 million. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the Group during the cumulative second quarter of the current fiscal year were ¥402.196 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current fiscal year.」
The disclosure that there have been no material changes in research and development activities continues. Total R&D expenses were ¥402.196 million. - FY2018-Q1RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current fiscal year.」
The disclosure that there have been no material changes in research and development activities continues. Total R&D expenses were ¥222.892 million. - FY2017AdvancedAnnual report
「These technologies are being applied to take-out robots, making them faster and more energy-efficient through weight reduction. Greater visibility into the design process also enables efficient design with fewer rework cycles. In addition, after reducing costs through VE and VA, including cost reduction (CD), these technologies are being rolled out across all product series.」
The disclosure states that, in addition to continuing R&D, research results from universities are being applied to products and the technologies are being rolled out across all product series. - FY2017-Q3RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The disclosure that there have been no material changes in research and development activities continues. Total R&D expenses were ¥451.570 million. - FY2017-Q2RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The policy of stating that there have been no material changes in research and development activities continues. Total R&D expenses were ¥243.493 million. - FY2017-Q1First statedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company states that there have been no material changes in its R&D activities.